Worldwide executive director of the Drug Information Association Paul Pomerantz talks to Neena Brizmohun about healthcare globalisation, the informed patient, comparative effectiveness and how the DIA plans to turn its knowledge into an asset...
Scrip Regulatory Affairs
DIA Director Homes in on Regulatory Hot Topics Ahead of 46th Annual Meeting
10 June 2010
Neena Brizmohun
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU's Innovative Medicines Initiative joins hands with US Critical Path Institute
- Industry mourns death of key figure and opinion leader Malcolm Carlisle
- US FDA lays out ambitious goals for driving drug and device innovation, but funding hazy
- EU guidance could jeopardise confidentiality, says industry, but consumers want more openness
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
